OPEN The New England journal of medicine | 18 Jul 2020
P Horby, WS Lim, JR Emberson, M Mafham, JL Bell, L Linsell, N Staplin, C Brightling, A Ustianowski, E Elmahi, B Prudon, C Green, T Felton, D Chadwick, K Rege, C Fegan, LC Chappell, SN Faust, T Jaki, K Jeffery, A Montgomery, K Rowan, E Juszczak, JK Baillie, R Haynes and MJ Landray
Coronavirus disease 2019 (Covid-19) is associated with diffuse lung damage. Glucocorticoids may modulate inflammation-mediated lung injury and thereby reduce progression to respiratory failure and death.
* Data courtesy of Altmetric.com